Cancer is responsible for approximately one out of every six human deaths, according to the World Health Organization. Cancer is described as uncontrolled cell proliferation in different places of the human body. Genetic mutations are mostly to blame.
Despite the fact that cancer has become a substantial cause of death, progress in developing new cancer treatments has been modest. Chemotherapy, radiation, and surgical tumor excision continue to be the mainstays of cancer treatment. Chemotherapy medications, as opposed to radiation or surgical intervention, may be a successful medication in the treatment of widespread cancer.
The majority of current cancer treatment approaches have substantial side effects since they are also harmful to healthy cells in the body. Furthermore, anti-cancer therapy may be very expensive for patients and time intensive to create.
It is fairly commonplace in the realm of medicine to identify or uncover novel effects of already approved pharmaceuticals, such as the use of low-dose aspirin to prevent heart attack.
Anticancer properties have been revealed in a number of currently used drugs when administered by persons diagnosed with cancer. Clinical researchers believe that these results have the potential not just to improve cancer treatment but also to reduce the time required to produce new anticancer drugs. This seems to be the case with this cancer-fighting canine dewormer.
Fenbendazole, a dewormer, may be effective in cancer therapy.
In veterinary medicine, fenbendazole is a common broad-spectrum anthelmintic/antiparasitic drug. Despite the fact that the dog dewormer fermandazole is used to cure parasites and hookworms, it has created a new potential of treating cancer when Joe Tippens employed Panacur C dog dewormer to treat his lung cancer. You read it correctly: a dog dewormer for cancer therapy.
Since Joe Tippens’ narrative of recovering from a malignant condition, fenbendazole has been a hot topic of controversy in the world of health. Fenbendazole cancer success tales have swept cancer forums and blogs. Some people are skeptical of the usage of fenbendazole in humans for cancer treatment, while others are following Joe’s cancer treatment regimens.
The Joe Tippens approach combines the use of fenbendazole, tumeric, CBD oil, and vitamin E as a therapeutic technique. In Joe’s regimen, vitamin E was regarded an optional component; currently, turmeric and CBD are the most crucial components.
Can humans consume dog deworming medication?
Since fenbendazole is primarily utilized as a dog dewormer, the issue of whether an animal dewormer is safe for people emerges. It has relatively minimal toxicity in comparison to standard anticancer medicines. Some studies have been undertaken to determine if fenbendazole is safe for people, and these investigations show that the dog deworming pill fenbendazole has a wide margin of safety. Fenbendazole tablets for dog deworming have nearly no negative effects and are regarded safe in a range of animals, including humans.
According to new studies, it may help destroy cancer cells and hence treat cancer. It affects on cancer cells in a number of ways, producing apoptosis (programmed cell death). This implies you’d be correct if you stated they repurposed dog treatment for human cancer.
How long does it take for fenbendazole to take effect?
Fenbendazole works primarily as a microtubule destabilizer. This dog dewormer for human cancer functions as a micro-destabilizing agent in the body, swiftly inhibiting malignant cell mitosis. Microtubules are unique proteins that play an important role in many activities of our body’s cells, especially those that proliferate rapidly, such as cancer cells.
Microtubules are required for cell architecture, nutrient transport, DNA synthesis, and a variety of other tasks. Because tumors rely on rapid cell division, it is critical to block these processes. Fenbendazole dog worming pills suppress the formation of microtubules in quickly developing cells. The mechanism of action of fenbendazole is to limit the process of fast division of cancer cells, which essentially implies that cancer is prevented in the body.
Cancer treatment that targets microtubules is not new. Many well-known cancer treatments, such as vinca alkaloids (vinblastine, vinflunine, and so on), paclitaxel, and docetaxel, accomplish this. Tubulin-binding drugs kill cancer cells by interfering with the dynamics of microtubules, which are required for DNA segregation and hence cell division.
Researchers discovered that when compared to other anticancer drugs such as nocodazole and colchicine, the fenbendazole dog dewormer had a lower effect on cellular microtubules. This is a good thing since it explains why fenbendazole is essentially non-toxic and less hazardous than these chemotherapeutic medications.
Interestingly, unlike taxanes (paclitaxel) and vinca alkaloids, dog dewormer showed no impact on p-glycoprotein expression in humans. Patients who are regularly provided taxanes or vinca alkaloids acquire resistance to these and many other drugs because to their impact on glycoprotein, but the immune system did not develop resistance to fenbendazole.
This means that cancer cells are far less likely to develop resistance to fenbendazole and other anticancer medications, which is a positive indication. Because many cancer treatment regimens lose efficacy over time, fenbendazole pills for humans have demonstrated promising outcomes in the treatment of cancer patients.
According to the most current laboratory study on cancer cells, up to 30% of cancer cells died after 32 hours of fenbendazole treatment. Fenbendazole was present throughout the division of these malignant cells. This experiment was carried out on a particularly aggressive kind of cancer cell known as non-small cell lung carcinoma (NSCLC). It took days in petri dishes, but it might take weeks or months in people to see the first effects of this canine dewormer for cancer.
